Page last updated: 2024-10-29

avapro and Shock

avapro has been researched along with Shock in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nielsen, EW1

Other Studies

1 other study available for avapro and Shock

ArticleYear
Hypotensive shock and angio-oedema from angiotensin II receptor blocker: a class effect in spite of tripled tryptase values.
    Journal of internal medicine, 2005, Volume: 258, Issue:4

    Topics: Angioedema; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Biphenyl Compounds; Female; Humans;

2005